Tucatinib Continuation Study

Clinical trial NCT07768358 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07768358
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Cervical Cancer Biliary Tract Neoplasms Urothelial Cancer Advanced Non-Small Cell Lung Cancer Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)Colorectal Cancer

Start date: 2026-08-24
Primary completion: 2032-03-13
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.